LEADER 00981nam a2200241 i 4500 001 991001198909707536 005 20020507185056.0 008 970603s1963 us ||| | eng 035 $ab10814504-39ule_inst 035 $aLE01308580$9ExL 040 $aDip.to Matematica$beng 082 0 $a510.9 100 1 $aKlein, Felix$057765 245 10$aOn Riemann's theory of algebraic functions and their integrals :$ba supplement to the usual treatises /$cby Felix Klein ; translated from the german by Frances Hardcastle 260 $aNew York :$bDover,$c1963 300 $axii, 76 p. ;$c20 cm. 650 4$aCollected works 907 $a.b10814504$b21-09-06$c28-06-02 912 $a991001198909707536 945 $aLE013 01A75 KLE14 (1963)$g1$i2013000085265$lle013$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i10920468$z28-06-02 996 $aOn Riemann's theory of algebraic functions and their integrals$9925300 997 $aUNISALENTO 998 $ale013$b01-01-97$cm$da $e-$feng$gus $h0$i1 LEADER 01157nam a2200289 i 4500 001 991001335949707536 008 110726s2010 it 001 0 ita 020 $a9788815138439 035 $ab13998407-39ule_inst 040 $aFacoltà SSPT$bita 082 0 $a301.01 100 1 $aBaert, Patrick$0147223 245 13$aLa teoria sociale contemporanea /$cPatrick Baert, Filipe Carreira Da Silva 250 $a2. ed. aggiornata 260 $aBologna :$bIl mulino,$cc2010 300 $a289 p. ;$c22 cm 440 0$aManuali.$pSociologia 650 4$aScienze sociali$xTeorie 650 4$aSociologia$xTeorie 700 1 $aCarreira da Silva, Filipe$eauthor$4http://id.loc.gov/vocabulary/relators/aut$0511175 907 $a.b13998407$b02-04-14$c26-07-11 912 $a991001335949707536 945 $aLE021 301.01 BAE01.02$g1$i2020000033257$lle021$op$pE26.00$q-$rn$so $t0$u0$v0$w0$x0$y.i15305181$z26-07-11 945 $aLE021 301.01 BAE01.02$g2$i2020000033240$lle021$op$pE26.00$q-$rn$s- $t0$u17$v1$w17$x0$y.i15305193$z26-07-11 996 $aTeoria sociale contemporanea$91441662 997 $aUNISALENTO 998 $ale020$b26-07-11$cm$da $e-$fita$git $h3$i0 LEADER 03968nam 22006734a 450 001 9910970994503321 005 20251017110141.0 010 $a9786612083914 010 $a9780309182744 010 $a0309182743 010 $a9781282083912 010 $a1282083910 010 $a9780309557849 010 $a0309557844 010 $a9780309528894 010 $a0309528895 035 $a(CKB)111069351126410 035 $a(EBL)3375213 035 $a(SSID)ssj0000104048 035 $a(PQKBManifestationID)11122675 035 $a(PQKBTitleCode)TC0000104048 035 $a(PQKBWorkID)10078613 035 $a(PQKB)11107650 035 $a(MiAaPQ)EBC3375213 035 $a(Au-PeEL)EBL3375213 035 $a(CaPaEBR)ebr10032410 035 $a(OCoLC)923255147 035 $a(Perlego)4739136 035 $a(DNLM)1148366 035 $a(BIP)7650717 035 $a(EXLCZ)99111069351126410 100 $a20020325d2002 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 04$aThe anthrax vaccine $eis it safe? does it work? /$fLois M. Joellenbeck ... [et al.], editors ; Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Medical Follow-up Agency, Institute of Medicine 205 $a1st ed. 210 $aWashington, D.C. $cNational Academy Press$dc2002 215 $a1 online resource (288 p.) 300 $aDescription based upon print version of record. 311 08$a9780309083096 311 08$a0309083095 320 $aIncludes bibliographical references. 327 $a""Front Matter""; ""Preface""; ""Acknowledgments""; ""Reviewers""; ""Contents""; ""Figures, Tables, and Boxes""; ""Abbreviations and Acronyms""; ""Executive Summary""; ""1 Introduction""; ""2 Background""; ""3 Anthrax Vaccine Efficacy""; ""4 Safety: Introduction""; ""5 Safety: Case Reports""; ""6 Safety: Epidemiologic Studies""; ""7 Anthrax Vaccine Manufacture""; ""8 Future Needs""; ""Appendix A Statement of Task""; ""Appendix B Biographical Sketches""; ""Appendix C Information-Gathering Meeting Agendas""; ""Appendix D Anthrax Vaccine Adsorbed Package Inserts"" 327 $a""Appendix E Vaccine Adverse Event Reporting System (VAERS) Form""""Appendix F Anthrax Vaccine Expert Committee (AVEC) Case Assessment Form""; ""Appendix G DMSS Analyses Requested by the IOM Committee to Assess the Safety and Efficacy of the Anthrax Vaccine""; ""An Assessment of the Safety of the Anthrax Vaccine A Letter Report Appendix H"" 330 $aThe vaccine used to protect humans against the anthrax disease, called Anthrax Vaccine Adsorbed (AVA), was licensed in 1970. It was initially used to protect people who might be exposed to anthrax where they worked, such as veterinarians and textile plant workers who process animal hair. When the U. S. military began to administer the vaccine, then extended a plan for the mandatory vaccination of all U. S. service members, some raised concerns about the safety and efficacy of AVA and the manufacture of the vaccine. In response to these and other concerns, Congress directed the Department of Defense to support an independent examination of AVA. The Anthrax Vaccine: Is It Safe? Does It Work? reports the study (TM)s conclusion that the vaccine is acceptably safe and effective in protecting humans against anthrax. The book also includes a description of advances needed in main areas: improving the way the vaccine is now used, expanding surveillance efforts to detect side effects from its use, and developing a better vaccine. 606 $aAnthrax$xVaccination 615 0$aAnthrax$xVaccination. 676 $a614.5/61 712 02$aInstitute of Medicine (U.S.).$bCommittee to Assess the Safety and Efficacy of the Anthrax Vaccine. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910970994503321 996 $aThe anthrax vaccine$94354082 997 $aUNINA